Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis

Immune checkpoint inhibitors (ICIs) has revolutionized the treatment of different advanced solid tumors, but most patients develop severe immune-related adverse events (irAEs). Although a bi-directional crosstalk between bone and immune systems is widely described, the effect of ICIs on the skeleton...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantano, Francesco, Tramontana, Flavia, Iuliani, Michele, Leanza, Giulia, Simonetti, Sonia, Piccoli, Alessandra, Paviglianiti, Annalisa, Cortellini, Alessio, Spinelli, Gian Paolo, Longo, Umile Giuseppe, Strollo, Rocky, Vincenzi, Bruno, Tonini, Giuseppe, Napoli, Nicola, Santini, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633734/
https://www.ncbi.nlm.nih.gov/pubmed/36338920
http://dx.doi.org/10.1016/j.jbo.2022.100459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633734/
https://www.ncbi.nlm.nih.gov/pubmed/36338920
http://dx.doi.org/10.1016/j.jbo.2022.100459

Ejemplares similares